333 related articles for article (PubMed ID: 19826103)
1. Long-term Fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosis.
Preitner F; Mody N; Graham TE; Peroni OD; Kahn BB
Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1420-9. PubMed ID: 19826103
[TBL] [Abstract][Full Text] [Related]
2. Fenretinide ameliorates insulin resistance and fatty liver in obese mice.
Koh IU; Jun HS; Choi JS; Lim JH; Kim WH; Yoon JB; Song J
Biol Pharm Bull; 2012; 35(3):369-75. PubMed ID: 22382323
[TBL] [Abstract][Full Text] [Related]
3. Fenretinide treatment prevents diet-induced obesity in association with major alterations in retinoid homeostatic gene expression in adipose, liver, and hypothalamus.
Mcilroy GD; Delibegovic M; Owen C; Stoney PN; Shearer KD; McCaffery PJ; Mody N
Diabetes; 2013 Mar; 62(3):825-36. PubMed ID: 23193184
[TBL] [Abstract][Full Text] [Related]
4. Fenretinide prevents obesity in aged female mice in association with increased retinoid and estrogen signaling.
Shearer KD; Morrice N; Henderson C; Reekie J; Mcilroy GD; McCaffery PJ; Delibegovic M; Mody N
Obesity (Silver Spring); 2015 Aug; 23(8):1655-62. PubMed ID: 26179846
[TBL] [Abstract][Full Text] [Related]
5. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.
Edmunds LR; Xie B; Mills AM; Huckestein BR; Undamatla R; Murali A; Pangburn MM; Martin J; Sipula I; Kaufman BA; Scott I; Jurczak MJ
Mol Metab; 2020 Nov; 41():101051. PubMed ID: 32653576
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
7. High-fat diet exacerbates cognitive and metabolic abnormalities in neuronal BACE1 knock-in mice - partial prevention by Fenretinide.
Plucińska K; Mody N; Dekeryte R; Shearer K; Mcilroy GD; Delibegovic M; Platt B
Nutr Neurosci; 2022 Apr; 25(4):719-736. PubMed ID: 32862802
[No Abstract] [Full Text] [Related]
8. CB(1) antagonism restores hepatic insulin sensitivity without normalization of adiposity in diet-induced obese dogs.
Kim SP; Woolcott OO; Hsu IR; Stefanoski D; Harrison LN; Zheng D; Lottati M; Kolka C; Catalano KJ; Chiu JD; Kabir M; Ionut V; Bergman RN; Richey JM
Am J Physiol Endocrinol Metab; 2012 May; 302(10):E1261-8. PubMed ID: 22374758
[TBL] [Abstract][Full Text] [Related]
9. Partial leptin deficiency confers resistance to diet-induced obesity in mice.
Zhao S; Li N; Zhu Y; Straub L; Zhang Z; Wang MY; Zhu Q; Kusminski CM; Elmquist JK; Scherer PE
Mol Metab; 2020 Jul; 37():100995. PubMed ID: 32289482
[TBL] [Abstract][Full Text] [Related]
10. Effects of exercise and low-fat diet on adipose tissue inflammation and metabolic complications in obese mice.
Vieira VJ; Valentine RJ; Wilund KR; Antao N; Baynard T; Woods JA
Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1164-71. PubMed ID: 19276393
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice.
Brachs S; Winkel AF; Tang H; Birkenfeld AL; Brunner B; Jahn-Hofmann K; Margerie D; Ruetten H; Schmoll D; Spranger J
Mol Metab; 2016 Nov; 5(11):1072-1082. PubMed ID: 27818933
[TBL] [Abstract][Full Text] [Related]
12. Global Tudor-SN transgenic mice are protected from obesity-induced hepatic steatosis and insulin resistance.
Wang X; Xin L; Duan Z; Zuo Z; Wang Y; Ren Y; Zhang W; Sun X; Liu X; Ge L; Yang X; Yao Z; Yang J
FASEB J; 2019 Mar; 33(3):3731-3745. PubMed ID: 30521378
[TBL] [Abstract][Full Text] [Related]
13. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.
Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T
EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299
[TBL] [Abstract][Full Text] [Related]
14. Reduced insulin suppression of glucose appearance is related to susceptibility to dietary obesity in rats.
Pagliassotti MJ; Horton TJ; Gayles EC; Koppenhafer TA; Rosenzweig TD; Hill JO
Am J Physiol; 1997 Apr; 272(4 Pt 2):R1264-70. PubMed ID: 9140029
[TBL] [Abstract][Full Text] [Related]
15. Dietary Eriodictyol Alleviates Adiposity, Hepatic Steatosis, Insulin Resistance, and Inflammation in Diet-Induced Obese Mice.
Kwon EY; Choi MS
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862092
[TBL] [Abstract][Full Text] [Related]
16. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.
Yang Q; Graham TE; Mody N; Preitner F; Peroni OD; Zabolotny JM; Kotani K; Quadro L; Kahn BB
Nature; 2005 Jul; 436(7049):356-62. PubMed ID: 16034410
[TBL] [Abstract][Full Text] [Related]
17. Long-term exposure to a high-fat diet results in the development of glucose intolerance and insulin resistance in interleukin-1 receptor I-deficient mice.
McGillicuddy FC; Reynolds CM; Finucane O; Coleman E; Harford KA; Grant C; Sergi D; Williams LM; Mills KH; Roche HM
Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E834-44. PubMed ID: 23921145
[TBL] [Abstract][Full Text] [Related]
18. Ginsenosides reduce body weight and ameliorate hepatic steatosis in high fat diet‑induced obese mice via endoplasmic reticulum stress and p‑STAT3/STAT3 signaling.
Yao Y
Mol Med Rep; 2020 Mar; 21(3):1059-1070. PubMed ID: 32016448
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice.
Cho SJ; Jung UJ; Choi MS
Br J Nutr; 2012 Dec; 108(12):2166-75. PubMed ID: 22414733
[TBL] [Abstract][Full Text] [Related]
20. Transthyretin Antisense Oligonucleotides Lower Circulating RBP4 Levels and Improve Insulin Sensitivity in Obese Mice.
Zemany L; Bhanot S; Peroni OD; Murray SF; Moraes-Vieira PM; Castoldi A; Manchem P; Guo S; Monia BP; Kahn BB
Diabetes; 2015 May; 64(5):1603-14. PubMed ID: 25524914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
